A comprehensive guide to the three biosimilar markets (Europe, US, Japan) and the regulatory pathways
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 57-59). === Generics in the pharmaceutical industry have been instrumental in reducing overall healthcare cost and allowing for greater d...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | English |
| Published: |
Massachusetts Institute of Technology
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/63227 |